Table of Content


FIGURES AND TABLES
PART 1. INTRODUCTION
? Report description
? Objectives of the study
? Market segment
? Years considered for the report
? Currency
? Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
? Introduction
? Drivers
? Restraints
? Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY PRODUCT
? Chimeric monoclonal antibodies
? Human monoclonal antibodies
? Humanized monoclonal antibodies
? Murine monoclonal antibodies
PART 6. MARKET BREAKDOWN BY MANUFACTURING PROCESS
? Mammalian cell culture
? Microbial fermentation
PART 7. MARKET BREAKDOWN BY INDICATION
? Cancer
? Autoimmune diseases
? Infectious diseases
? Inflammatory diseases
? Others
PART 8. MARKET BREAKDOWN BY APPLICATION
? Therapeutic
? Diagnostic
? Research
PART 9. MARKET BREAKDOWN BY END USER
? Hospitals
? Research institutes
? Others
PART 10. MARKET BREAKDOWN BY REGION
? North America
? Asia Pacific
? Europe
? Rest of the World (ROW)
PART 11. KEY COMPANIES
? AbbVie Inc.
? Amgen Inc.
? AstraZeneca plc
? Bristol-Myers Squibb Company
? Daiichi Sankyo Company, Limited
? Eli Lilly and Company
? F. Hoffmann-La Roche AG
? GlaxoSmithKline plc.
? Johnson & Johnson
? Merck & Co., Inc.
? Novartis International AG
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER